-
-
Bromobis[(2,3-butanedione dioximato)-N,N′][4-(1,1-dimethylethyl)pyridine]-Cobalt,98%, 5g
-
2-Butyl-3-((2′-(2-trityl-2H-tetrazol-5-yl)-[1,1′-bi
phenyl]-4-yl)methyl)-1,3-diazaspiro[4.4]non-1-en-4-one,97%, 25g
-
2-Butyl-3-((2′-(2-trityl-2H-tetrazol-5-yl)-[1,1′-bi
phenyl]-4-yl)methyl)-1,3-diazaspiro[4.4]non-1-en-4-one,97%, 1g
-
2-Butyl-3-((2′-(2-trityl-2H-tetrazol-5-yl)-[1,1′-bi
phenyl]-4-yl)methyl)-1,3-diazaspiro[4.4]non-1-en-4-one,97%, 5g
-
2-Heneicosanone,95%, 1g
-
2-Heneicosanone,95%, 100mg
-
2-Heneicosanone,95%, 250mg
-
1-Benzyl-8-methyl-1,4,8-triazaspiro[4.5]decan-2-one,97%, 50mg
-
1-Benzyl-8-methyl-1,4,8-triazaspiro[4.5]decan-2-one,97%, 100mg
-
1-Benzyl-8-methyl-1,4,8-triazaspiro[4.5]decan-2-one,97%, 250mg
-
1-Methoxy-3-(methylsulfonyl)benzene,98%, 1g
стр.: